A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel-group Study Of Oral Cp-690,550 As An Induction Therapy In Subjects With Moderate To Severe Ulcerative Colitis
收藏DataCite Commons2026-03-02 更新2024-07-13 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006774/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is designed to evaluate the efficacy and safety of tofacitinib (CP-690,550) in
patients with moderate to severe ulcerative colitis who have failed or be intolerant to one
of following treatments for ulcerative colitis: oral steroids,
azathiopurine/6-mercaptopurine, or anti-TNF-alpha therapy.
提供机构：
Vivli
创建时间：
2021-04-02
